News
PPBT
1.510
+2.03%
0.030
H.C. Wainwright Remains a Buy on Purple Biotech (PPBT)
TipRanks · 5d ago
Weekly Report: what happened at PPBT last week (0914-0918)?
Weekly Report · 6d ago
Weekly Report: what happened at PPBT last week (0907-0911)?
Weekly Report · 09/14 09:45
Purple Biotech Shareholders Approve All AGM Proposals, File Results with U.S. SEC
TipRanks · 09/09 20:28
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 09/08 21:06
Weekly Report: what happened at PPBT last week (0831-0904)?
Weekly Report · 09/07 09:42
3 Penny Stocks on Investors’ Radar after Big Moves, 9/03/26
TipRanks · 09/03 11:31
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 09/02 17:06
Crude Oil Moves Higher; US Factory Orders Rise In July
Benzinga · 09/02 16:01
Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings
Benzinga · 09/02 13:42
Why Is Purple Biotech Stock Gaining Wednesday?
Benzinga · 09/02 13:24
Why Is Purple Biotech (PPBT) Stock 42% Up Today?
TipRanks · 09/02 13:22
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 09/02 12:07
Purple Biotech Gains New U.S. Patent Allowance for CAPTN-3 Cancer Immunotherapy Platform
TipRanks · 09/02 12:00
Purple Biotech issued notice of allowance from USPTO
TipRanks · 09/02 11:50
Purple Biotech Issued Patent From U.S. Patent And Trademark Office For Its Application Covering Tri-Specific Antibody Constructs, Models
Benzinga · 09/02 11:32
New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies
Barchart · 09/02 06:30
Weekly Report: what happened at PPBT last week (0824-0828)?
Weekly Report · 08/31 09:46
Weekly Report: what happened at PPBT last week (0817-0821)?
Weekly Report · 08/24 09:46
Weekly Report: what happened at PPBT last week (0810-0814)?
Weekly Report · 08/17 09:47
More
Webull provides a variety of real-time PPBT stock news. You can receive the latest news about Purple Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.